Biotech Venture Funding April 2026
Private financings from April 2026 — Company, date, round, investors, therapeutic area, and a one-line "what they do."
Latest VC deals here →
2026 VC Tracker
Last updated:
15 May 2026
April 2026
Vivacta Bio
Series A / A+
Date:
29-Apr-2026
|
Size:
US$50M+
|
Therapeutic area:
Oncology / in vivo CAR-T
Investors:
Loyal Valley Capital, Decheng Capital, OrbiMed, Hankang Capital, Eisai Innovation Inc., C&D Emerging Industry Equity Investment, Qiming Venture Partners, Beijing Shunxi, and Apricot Capital
What they do:
China-based biotech developing in vivo CAR-T therapies. Proceeds will advance lead candidate GT801, currently in Phase 1 for relapsed or refractory CD19-positive B-cell malignancies, support regulatory preparations, and expand the company’s in vivo CAR-T platform.
Coultreon Biopharma
Series A
Date:
28-Apr-2026
|
Size:
US$125M
|
Therapeutic area:
Immunology / autoimmune disease
Investors:
Led by Sofinnova Investments and co-led by Forbion and Novo Holdings, with participation from Galapagos, Regeneron Ventures, Balyasny Asset Management, Luma Group, Samsara BioCapital, Longwood Fund, and Finchley Healthcare Ventures
What they do:
Belgium-based immunology biotech, formerly Onco3R Therapeutics, advancing COL-5671, an oral SIK3 inhibitor licensed from Galapagos. Proceeds will support development across autoimmune indications including psoriasis and ulcerative colitis.
Tortugas Neuroscience
Seed + Series A
Date:
21-Apr-2026
|
Size:
US$106M
|
Therapeutic area:
Neurology / neuropsychiatry
Investors:
Cure Ventures led the seed round and co-led the Series A with The Column Group and AN Venture Partners
What they do:
Neuroscience company launched by former Sage Therapeutics executives with a pipeline of four Phase 2-stage assets licensed from Eisai and Hansoh. The financing supports ongoing development across neuropsychiatry and neurology programs including candidates for major depressive disorder, generalized anxiety disorder, Alzheimer’s disease psychosis, and Parkinson’s disease psychosis.